Effects of human umbilical cord blood-derived mesenchymal stromal cells and dermal fibroblasts on diabetic wound healing
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Moon, Kyung-Chul | - |
dc.contributor.author | Lee, Jong-Seok | - |
dc.contributor.author | Han, Seung-Kyu | - |
dc.contributor.author | Lee, Hyup-Woo | - |
dc.contributor.author | Dhong, Eun-Sang | - |
dc.date.accessioned | 2021-09-03T04:10:09Z | - |
dc.date.available | 2021-09-03T04:10:09Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2017-07 | - |
dc.identifier.issn | 1465-3249 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/82878 | - |
dc.description.abstract | Background aims. A previous study demonstrated that human umbilical cord blood derived mesenchymal stromal cells (hUCB-MSCs) have superior wound-healing activity compared with fibroblasts in vitro. However, wound healing in vivo is a complex process that involves multiple factors. The purpose of this study was to compare the effects of hUCB-MSCs and fibroblasts on diabetic wound healing in vivo. This study especially focused on collagen synthesis and angiogenesis, which are considered to be the important factors affecting diabetic wound healing. Methods. Porous polyethylene discs were loaded with either fibroblasts or hUCB-MSCs, and a third group, which served as a control, was not loaded with cells. The discs were then implanted in the back of diabetic mice. During the first and the second week after implantation, the discs were harvested, and collagen level and microvascular density were compared. Results. In terms of collagen synthesis, the hUCB-MSC group showed the highest collagen level (117.7 +/- 8.9 ng/mL), followed by the fibroblast group (83.2 +/- 5.2 ng/mL) and the no-cell group (60.0 +/- 4.7 ng/mL) in the second week after implantation. In terms of angiogenesis, the microvascular density in the hUCB-MSC group was 56.8 +/- 16.4, which was much higher than that in the fibroblast group (14.3 +/- 4.0) and the no-cell group (5.7 +/- 2.1) in the second week after implantation. Conclusions. These results demonstrate that hUCB-MSCs are superior to fibroblasts in terms of their effect on diabetic wound healing in vivo. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCI LTD | - |
dc.subject | ENDOTHELIAL GROWTH-FACTOR | - |
dc.subject | POROUS POLYETHYLENE IMPLANTS | - |
dc.subject | BONE-MARROW | - |
dc.subject | FOOT ULCERS | - |
dc.subject | STEM-CELLS | - |
dc.subject | COLLAGEN-SYNTHESIS | - |
dc.subject | IN-VITRO | - |
dc.subject | TISSUE | - |
dc.subject | SUBSTITUTE | - |
dc.subject | EXPRESSION | - |
dc.title | Effects of human umbilical cord blood-derived mesenchymal stromal cells and dermal fibroblasts on diabetic wound healing | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Han, Seung-Kyu | - |
dc.contributor.affiliatedAuthor | Dhong, Eun-Sang | - |
dc.identifier.doi | 10.1016/j.jcyt.2017.03.074 | - |
dc.identifier.scopusid | 2-s2.0-85018770016 | - |
dc.identifier.wosid | 000403976600005 | - |
dc.identifier.bibliographicCitation | CYTOTHERAPY, v.19, no.7, pp.821 - 828 | - |
dc.relation.isPartOf | CYTOTHERAPY | - |
dc.citation.title | CYTOTHERAPY | - |
dc.citation.volume | 19 | - |
dc.citation.number | 7 | - |
dc.citation.startPage | 821 | - |
dc.citation.endPage | 828 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalResearchArea | Biotechnology & Applied Microbiology | - |
dc.relation.journalResearchArea | Hematology | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Cell & Tissue Engineering | - |
dc.relation.journalWebOfScienceCategory | Biotechnology & Applied Microbiology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Hematology | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.subject.keywordPlus | ENDOTHELIAL GROWTH-FACTOR | - |
dc.subject.keywordPlus | POROUS POLYETHYLENE IMPLANTS | - |
dc.subject.keywordPlus | BONE-MARROW | - |
dc.subject.keywordPlus | FOOT ULCERS | - |
dc.subject.keywordPlus | STEM-CELLS | - |
dc.subject.keywordPlus | COLLAGEN-SYNTHESIS | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | TISSUE | - |
dc.subject.keywordPlus | SUBSTITUTE | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordAuthor | angiogenesis | - |
dc.subject.keywordAuthor | collagen | - |
dc.subject.keywordAuthor | diabetic wound healing | - |
dc.subject.keywordAuthor | fibroblast | - |
dc.subject.keywordAuthor | human umbilical cord blood derived mesenchymal stromal cell | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.